Published

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: UNC Libraries
Date: 2024-06-07
Source: OpenAlex
DOI: 10.17615/yb2v-ca64
PubMed: Unavailable

Authors

Ouliana Panova Nichols D.E Shoichet B.K Lyu J Georgios Skiniotis Che T Roth B.L DiBerto J.F Daniel Wacker Robertson M.J Kami Kim Krumm B.E Seven A.B

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety Pharmacology Receptor Pharmacology Drug Interactions Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor2024-06-07

Related papers

In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A ReceptorBook of Proceedings · 2025-01-01 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-18 Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10 Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-13 Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled TrialClinicalTrials.gov · 2026-07-14